Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 225

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

Open access
The Parkinson’s Progression Marker Initiative, Kang, Ju-Hee, Mollenhauer, Brit, Coffey, Christopher S., Toledo, Jon B., Weintraub, Daniel, Galasko, Douglas R., Irwin, David J., Van Deerlin, Vivianna, Chen-Plotkin, Alice S., Caspell-Garcia, Chelsea, Waligórska, Teresa, Taylor, Peggy, Shah, Nirali, Pan, Sarah, Zero, Pawel, Frasier, Mark, Marek, Kenneth, Kieburtz, Karl, Jennings, Danna, Tanner, Caroline M., Simuni, Tanya, Singleton, Andrew, Toga, Arthur W., Chowdhury, Sohini, Trojanowski, John Q., Shaw, Leslie M.·2016·Acta Neuropathologica

Abstract

The development of biomarkers to predict the progression of Parkinson’s disease (PD) from its earliest stage through its heterogeneous course is critical for research and therapeutic development. The Parkinson’s Progression Markers Initiative (PPMI) study is an ongoing international multicenter, prospective study to validate biomarkers in drug-naïve PD patients and matched healthy controls (HC). We quantified cerebrospinal fluid (CSF) alpha-synuclein (α-syn), amyloid-beta1-42 (Aβ1-42), total tau (t-tau), and tau phosphorylated at Thr181 (p-tau) in 660 PPMI subjects at baseline, and correlated these data with measures of the clinical features of these subjects. We found that CSF α-syn, t-tau and p-tau levels, but not Aβ1-42, were significantly lower in PD compared with HC, while the diagnostic value of the individual CSF biomarkers for PD diagnosis was limited due to large overlap. The level of α-syn, but not other biomarkers, was significantly lower in PD patients with non-tremor-dominant phenotype compared with tremor-dominant phenotype. In addition, in PD patients the lowest Aβ1-42, or highest t-tau/Aβ1-42 and t-tau/α-syn quintile in PD patients were associated with more severe non-motor dysfunction compared with the highest or lowest quintiles, respectively. In a multivariate regression model, lower α-syn was significantly associated with worse cognitive test performance. APOE ε4 genotype was associated with lower levels of Aβ1-42, but neither with PD diagnosis nor cognition. Our data suggest that the measurement of CSF biomarkers in early-stage PD patients may relate to disease heterogeneity seen in PD. Longitudinal observations in PPMI subjects are needed to define their prognostic performance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-016-1552-2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 225

Metadata

Authors
Initiative, T. P. P. M., Kang, J.-H., Mollenhauer, B., Coffey, C. S., Toledo, J. B., Weintraub, D., Galasko, D. R., Irwin, D. J., Van Deerlin, V., Chen-Plotkin, A. S., Caspell-Garcia, C., Waligórska, T., Taylor, P., Shah, N., Pan, S., Zero, P., Frasier, M., Marek, K., Kieburtz, K., Jennings, D., Tanner, C. M., Simuni, T., Singleton, A., Toga, A. W., Chowdhury, S., Trojanowski, J. Q., & Shaw, L. M.
Venue
Acta Neuropathologica
Published
2016-03-28
Volume
131
Issue
6
Pages
935-949
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2330640534
Cited by
225
References
6
FWCI
15.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study. https://app.cochat.ai/papers/10.1007/s00401-016-1552-2
The paper
Initiative, T. P. P. M., Kang, J.-H., Mollenhauer, B., Coffey, C. S., Toledo, J. B., Weintraub, D., Galasko, D. R., Irwin, D. J., Van Deerlin, V., Chen-Plotkin, A. S., Caspell-Garcia, C., Waligórska, T., Taylor, P., Shah, N., Pan, S., Zero, P., Frasier, M., Marek, K., Kieburtz, K., . . . Shaw, L. M. (2016). CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study. Acta Neuropathologica. https://doi.org/10.1007/s00401-016-1552-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.